Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects (2016)
- Authors:
- USP affiliated authors: GUIMARAES, ELAINE APARECIDA DEL BEL BELLUZ - FORP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; ZUARDI, ANTONIO WALDO - FMRP ; GUIMARÃES, FRANCISCO SILVEIRA - FMRP
- Schools: FORP; FMRP
- DOI: 10.1371/journal.pone.0158779
- Subjects: CANABINOIDES; FLUORAÇÃO; NEUROPSIQUIATRIA; FARMACOLOGIA
- Language: Inglês
- Imprenta:
- Place of publication: San Francisco
- Date published: 2016
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
BREUER, Aviva et al. Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. PLOS ONE, v. 11, 2016Tradução . . Disponível em: http://dx.doi.org/10.1371/journal.pone.0158779. Acesso em: 03 jul. 2022. -
APA
Breuer, A., Haj, C. G., Fogaça, M. V., Gomes, F. V., Silva, N. R., Pedrazzi, J. F., et al. (2016). Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. PLOS ONE, 11. doi:10.1371/journal.pone.0158779 -
NLM
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JEC, Crippa JA de S, Zuardi AW, Mechoulam R, Guimarães FS. Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects [Internet]. PLOS ONE. 2016 ; 11[citado 2022 jul. 03 ] Available from: http://dx.doi.org/10.1371/journal.pone.0158779 -
Vancouver
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JEC, Crippa JA de S, Zuardi AW, Mechoulam R, Guimarães FS. Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects [Internet]. PLOS ONE. 2016 ; 11[citado 2022 jul. 03 ] Available from: http://dx.doi.org/10.1371/journal.pone.0158779 - Correction: Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects
- Canabidiol: possíveis aplicacões terapêuticas em psicopatologias
- Effects of minocycline on regional cerebral blood flow in schizophrenia
- A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
- Cannabidiol, a cannabis sativa constituent, as an antipsycholic drug
- Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia
- Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning?
- Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implication for neuroprotection
Informações sobre o DOI: 10.1371/journal.pone.0158779 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 002789246.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
